Fig. 1From: Verification of B-lymphocyte activating factor’s involvement in the exacerbation of insulin resistance as well as an autoimmune response in patients with nonalcoholic steatohepatitis and patients with HCV-related chronic liver diseaseTiters and immunofluorescence patterns of ANA in patients with NASH and patients with CLD-C. ANA antinuclear antibody, NASH nonalcoholic steatohepatitis, CLD-C HCV-related chronic liver diseaseBack to article page